Bio Details

Carlos Carrillo, Ph.D., M.Sc., brings more than 29 years of exceptional experience in developing innovative biological and drug products from concept to commercialization, small and large molecules. Dr. Carlos Carrillo has dedicated his career to advancing therapies in diverse areas such as infectious disease vaccines, autoimmune diseases, oncology (including non-small cell lung cancer, kidney, and breast cancer), kidney transplants, and ophthalmology. He has an extensive track record of working with key regulatory bodies, including the FDA,HC, EMA,MHRA, TGA, ANVISA and COFEPRIS and has played a pivotal role in leading and managing meetings across various divisions of those organizations.